Regarding inflammatory cytokines, imiquimod-induced skin inflammation was reported to be ameliorated but not abolished in IL-17 receptor A-deficient mice and that the inflammation was mediated by TNF-α and IL-6, suggesting their importance in the inflammation [36]. The gene discussed is IL17RA; the disease is dermatitis.